Literature DB >> 9064345

Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.

L Reininger1, T H Winkler, C P Kalberer, M Jourdan, F Melchers, A G Rolink.   

Abstract

We have previously shown that long-term in vitro proliferating fetal liver pre-B cell lines derived from autoimmune-prone (NZB x NZW)F1 (BW) mice, but not normal (B6 x DBA2)F1 mice, can differentiate in severe combined immunodeficient (SCID) mice to produce elevated levels of serum immunoglobulin (Ig) M and IgG, and high titers of antinuclear antibodies The contribution of parental NZB and NZW strains to B cell abnormalities of BW hybrid mice was investigated here by preparing pre-B cells and transferring them into immunodeficient SCID- and RAG-2-targeted mice. We show that transfer of NZB pre-B cells led to a marked IgM hypergammaglobulinemia and to the production of limited amounts of IgG2a. On the other hand, the transfer of NZW pre-B cell lines led to moderately elevated IgM levels and marked hypergammaglobulinemia of IgG2a. High IgM and low IgG anti-DNA titers are found in the recipients of NZB pre-B cells, whereas those receiving NZW pre-B cells contained lower levels of IgM and high titers of IgG anti-DNA. In marked contrast, essentially identical titers of antibodies directed against a non-self-antigen, DNP, are found in all group of pre-B cell recipients. Thus, B-lineage cells of both NZB and NZW parental strains manifest abnormalities associated with the development of this lupus-like disease. Therefore, the present study strongly suggests a complex inheritance of B cell abnormalities in autoimmune-prone (NZB x NZW)F1 mice and emphasizes the critical importance of intrinsic B cell defects in the development of murine systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9064345      PMCID: PMC2192772          DOI: 10.1084/jem.184.3.853

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice.

Authors:  B J HELYER; J B HOWIE
Journal:  Nature       Date:  1963-01-12       Impact factor: 49.962

2.  Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB X NZW)F1 hybrid.

Authors:  A Kohno; H Yoshida; K Sekita; N Maruyama; S Ozaki; S Hirose; T Shirai
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.

Authors:  M Gioud; B L Kotzin; R L Rubin; F G Joslin; E M Tan
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

4.  Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.

Authors:  N Maruyama; F Furukawa; Y Nakai; Y Sasaki; K Ohta; S Ozaki; S Hirose; T Shirai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  Precocious and enhanced functional maturation of B lineage cells in New Zealand Black mice during embryonic development.

Authors:  H Jyonouchi; P W Kincade
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

6.  Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice.

Authors:  S Hirose; R Nagasawa; I Sekikawa; M Hamaoki; Y Ishida; H Sato; T Shirai
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

7.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

8.  Induction of murine autoimmune disease by chronic polyclonal B cell activation.

Authors:  L Hang; J H Slack; C Amundson; S Izui; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  B cell dependence on and response to accessory signals in murine lupus strains.

Authors:  G J Prud'homme; R S Balderas; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZB X NZW mice.

Authors:  S Izui; J H Elder; P J McConahey; F J Dixon
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

3.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 4.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

Review 5.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 6.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

7.  A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.

Authors:  S Ono; D Shao; S Yamada; Y Yang; M Yamashita; T Hamaoka
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

8.  Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.

Authors:  H B Richards; M Satoh; J C Jennette; T Okano; Y S Kanwar; W H Reeves
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 9.  Indications for use and safety of rituximab in childhood renal diseases.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2012-09-21       Impact factor: 3.714

10.  A mutational analysis of the Abetaz/Aalphad major histocompatibility complex class II molecule that restricts autoreactive T cells in (NZBxNZW)F1 mice. The critical influence of alanine at position 69 in the Aalphad chain.

Authors:  T Sai; M Mine; M Fukuoka; S Koarada; M Kimoto
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.